#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antiphospholipid syndrome Pulmonary fibrosis Enteritis Short-bowel syndrome Duchenne muscular dystrophy gene carrier Osteochondrodysplasia Hepatocellular carcinoma Hodgkin's disease Mantle cell lymphoma stage IV Interstitial lung disease Anti-myelin-associated glycoprotein antibodies positive Scleroderma associated digital ulcer Myeloid leukaemia PIK3CA related overgrowth spectrum Anal fistula More trials…

    Learn about Rare Diseases

    Rett syndrome – Diagnostics Mast cell activation syndrome – Basic Information Alport’s syndrome – Life with Disease Wolfram syndrome – Treatment Haemophilia B without inhibitors – Basic Information SAPHO syndrome – Life with Disease Adrenogenital syndrome – Basic Information Paroxysmal nocturnal haemoglobinuria – Life with Disease Leiomyosarcoma – Diagnostics Ornithine transcarbamoylase deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Romiplostim Fludarabine Phosphate Ph. Eur. Upacicalcet Sodium Hydrate Folinic Acid APAZUNERSEN Glucocorticoids Dexamethasone Ph. Eur. PARECOXIB Transcon Il-2Β/Γ Ab-729 Mesenchymal Cells Rilpivirine Hydrochloride Human Cancellous Bone Volixibat Enfortumab Vedotin Osilodrostat Gallium (68Ga) Psma-R2 Mesna Diltiazem Isoprenaline Hydrochloride More therapies…

    Learn about Your Condition

    Haemoglobinuria Asthma Oxygen saturation Alport's syndrome Lung neoplasm malignant Cervix carcinoma recurrent Amnestic disorder Brain cancer metastatic Vulval cancer Acromegaly Cutaneous lupus erythematosus Dyskinesia Coma Viral infection Hyperkalaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Reproductive and Urinary Physiological Phenomena

  • Study of Follitropin Delta, Triptorelin and Choriogonadotropin Alfa for Ovulation Trigger in IVF with Fresh Transfer in Women with Low Ovarian Reserve

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diminished ovarian reserve
    • Infertility female
    Investigated Drugs:
    • Choriogonadotropin Alfa
    • Follitropin Delta
    • Ganirelix
    Spain
  • Study of vaginal pentoxifylline gel PKB171 compared to placebo in couples with mild male infertility due to low sperm count or poor sperm movement

    Recruiting

    4 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Pentoxifylline
    Spain
  • Study on Sentinel Lymph Node Technique in Early-Stage Ovarian Cancer Using Pertechnetate (99mTc) Sodium, Human Serum Albumin, and Indocyanine Green

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Serum Albumin
    • Pertechnetate (99Mtc) Sodium
    • Indocyanine Green
    Spain
  • Study on Letrozole and Gonadotropins for Women with Polycystic Ovary Syndrome (PCOS) to Improve Live Birth Rates

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    Investigated Drugs:
    • Follitropin Alfa
    • HUMAN MENOPAUSAL GONADOTROPHINS
    • Letrozole
    The Netherlands
  • Study on the Effectiveness of BP1.4979 for Adult Men with Premature Ejaculation

    Recruiting

    2 1
    Investigated Drugs:
    • N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide
    France
  • Comparison of Oxytocin versus Prostaglandins (Dinoprostone and Misoprostol) for Labor Induction in Women with Unfavorable Cervix After Initial Cervical Ripening

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dinoprostone
    • Misoprostol
    • Oxytocin
    France
1 2 3 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!